Managing menopausal symptoms after cancer

References

• Hickey M, Szabo RA, Hunter MS. Non-hormonal treatments for menopausal symptoms. BMJ 2017;359:j5101
   PubMedGoogle Scholar
• Mishra GD, Kuh D. Health symptoms during midlife in relation to menopausal transition: British prospective cohort study. BMJ 2012;344:e402
   PubMed Web of Science ®Google Scholar
• Marino JL, McNamara HC, Hickey M. Managing menopausal symptoms after cancer: an evidence-based approach for primary care. Med J Aust 2018;208:127–32
   PubMed Web of Science ®Google Scholar
• Pinkerton JV, Abraham L, Bushmakin AG, et al. Relationship between changes in vasomotor symptoms and changes in menopause-specific quality of life and sleep parameters. Menopause 2016;23:1060–6
   PubMed Web of Science ®Google Scholar
• Torre LA, Islami F, Siegel RL, Ward EM, Jemal A. Global cancer in women: burden and trends. Cancer Epidemiol Biomarkers Prev 2017;26:444–57
   PubMed Web of Science ®Google Scholar
• Ganz PA, Yip CH, Gralow JR, et al. Supportive care after curative treatment for breast cancer (survivorship care): resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement. Breast 2013;22:606–15
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394–424
   PubMed Web of Science ®Google Scholar
• Overbeek A, van den Berg MH, van Leeuwen FE, et al. Chemotherapy-related late adverse effects on ovarian function in female survivors of childhood and young adult cancer: a systematic review. Cancer Treatment Rev 2017;53:10–24
   PubMed Web of Science ®Google Scholar
• Davis SR, Panjari M, Robinson PJ, et al. Menopausal symptoms in breast cancer survivors nearly 6 years after diagnosis. Menopause 2014;21:1075–81
   PubMed Web of Science ®Google Scholar
• Marino JL, Saunders CM, Emery LI, et al. Nature and severity of menopausal symptoms and their impact on quality of life and sexual function in cancer survivors compared with women without a cancer history. Menopause 2014;21:267–74
   PubMed Web of Science ®Google Scholar
• Harlow SD, Gass M, Hall JE, et al. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. Climacteric 2012;15:105–14
   PubMed Web of Science ®Google Scholar
• Sukumvanich P, Case LD, Van Zee K, et al. Incidence and time course of bleeding after long-term amenorrhea after breast cancer treatment: a prospective study. Cancer 2010;116:3102–11
   PubMed Web of Science ®Google Scholar
• Scanlon M, Blaes A, Geller M, Majhail NS, Lindgren B, Haddad T. Patient satisfaction with physician discussion of treatment impact on fertility, menopause and sexual health among pre-menopausal women with cancer. J Cancer 2012;3:217–25
   PubMed Web of Science ®Google Scholar
• de Villiers TJ, Hall JE, Pinkerton JV, et al. Revised global consensus statement on menopausal hormone therapy. Climacteric 2016;19:313–15
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence. Menopause: diagnosis and management. NICE guideline (NG 23), 2015. Available from: https://www.nice.org.uk/guidance/ng23/chapter/Recommendations-for-research [last accessed 16 Jul 2019]
   Google Scholar
• Furness S, Roberts H, Marjoribanks J, et al. Hormone therapy in postmenopausal women and risk of endometrial hyperplasia. Cochrane Database Syst Rev 2012;15:CD000402
   Google Scholar
• Formoso G, Perrone E, Maltoni S, et al. Short-term and long-term effects of tibolone in postmenopausal women. Cochrane Database Syst Rev 2016;10:CD008536
   PubMedGoogle Scholar
• Kenemans P, Bundred NJ, Foidart J-M, et al. Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial. Lancet Oncol 2009;10:135–46
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence. Early and locally advanced breast cancer: diagnosis and treatment: NICE Clinical Guideline [CG80], 2009. https://www.nice.org.uk/guidance/cg80 [last accessed 16 Jul 2019]
   Google Scholar
• Kuhle CL, Kapoor E, Sood R, et al. Menopausal hormone therapy in cancer survivors: a narrative review of the literature. Maturitas 2016;92:86–96
   PubMed Web of Science ®Google Scholar
• Marjoribanks J, Farquhar C, Roberts H, Lethaby A. Trial does not change the conclusions of Cochrane review of long term hormone therapy for perimenopausal and postmenopausal women. BMJ 2012;345:e8141
   PubMedGoogle Scholar
• Del Carmen MG, Rice LW. Management of menopausal symptoms in women with gynecologic cancers. Gynecol Oncol 2017;146:427–35
   PubMed Web of Science ®Google Scholar
• O'Donnell RL, Clement KM, Edmondson RJ. Hormone replacement therapy after treatment for a gynaecological malignancy. Curr Opin Obstet Gynecol 2016;28:32–41
   PubMed Web of Science ®Google Scholar
• Domchek S, Kaunitz AM. Use of systemic hormone therapy in BRCA mutation carriers. Menopause 2016;23:1026–7
   PubMed Web of Science ®Google Scholar
• Finch A, Metcalfe KA, Chiang JK, et al. The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation. Gynecol Oncol 2011;121:163–8
   PubMed Web of Science ®Google Scholar
• Chan JL, Senapati S, Johnson LNC, et al. Risk factors for sexual dysfunction in BRCA mutation carriers after risk-reducing salpingo-oophorectomy. Menopause 2019;26:132–9
   PubMed Web of Science ®Google Scholar
• Gaudard A, Silva de Souza S, Puga MES, et al. Bioidentical hormones for women with vasomotor symptoms. Cochrane Database Syst Rev 2016(8);CD010407
   PubMed Web of Science ®Google Scholar
• Lethaby A, Ayeleke RO, Roberts H. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev 2016(8);CD001500
   PubMed Web of Science ®Google Scholar
• Ponzone R, Biglia N, Jacomuzzi ME, et al. Vaginal oestrogen therapy after breast cancer: is it safe? Eur J Cancer 2005;41:2673–81
   PubMed Web of Science ®Google Scholar
• Stuenkel CA, Davis SR, Gompel A, et al. Treatment of symptoms of the menopause: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2015;100:3975–4011
   PubMed Web of Science ®Google Scholar
• Dew JE, Wren BG, Eden JA. A cohort study of topical vaginal estrogen therapy in women previously treated for breast cancer. Climacteric 2003;6:45–52
   PubMed Web of Science ®Google Scholar
• O'Meara ES, Rossing MA, Daling JR, et al. Hormone replacement therapy after a diagnosis of breast cancer in relation to recurrence and mortality. J Natl Cancer Inst 2001;93:754–62
   PubMed Web of Science ®Google Scholar
• Le Ray I, Dell’Aniello S, Bonnetain F, et al. Local estrogen therapy and risk of breast cancer recurrence among hormone-treated patients: a nested case–control study. Breast Cancer Res Treat 2012;135:603–19
   PubMed Web of Science ®Google Scholar
• Melisko ME, Goldman ME, Hwang J, et al. Vaginal testosterone cream vs estradiol vaginal ring for vaginal dryness or decreased libido in women receiving aromatase inhibitors for early-stage breast cancer: a randomized clinical trial. JAMA Oncol 2017;3:313–19
   PubMed Web of Science ®Google Scholar
• Hunter MS, Griffiths A, Mann E, et al. NICE guidance on Menopause: cognitive behavioural therapy is an effective non-hormonal intervention for managing vasomotor symptoms. BMJ 2015;351:h6434
   PubMedGoogle Scholar
• Stefanopoulou E, Hunter MS. Does pattern recognition software using the Bahr monitor improve the sensitivity, specificity, and concordance of ambulatory skin conductance monitoring of hot flushes?. Menopause 2013;20:1133–8
   PubMed Web of Science ®Google Scholar
• Elkins G, Marcus J, Stearns V, et al. Randomized trial of a hypnosis intervention for treatment of hot flashes among breast cancer survivors. JCO 2008;26:5022–6
   PubMed Web of Science ®Google Scholar
• Elkins GR, Fisher WI, Johnson AK, et al. Clinical hypnosis in the treatment of postmenopausal hot flashes. a randomized controlled trial. Menopause 2013;20:291–8
   PubMed Web of Science ®Google Scholar
• Dodin S, Blanchet C, Marc I, et al. Acupuncture for menopausal hot flushes. Cochrane Database Syst Rev 2013(7);CD007410
   PubMed Web of Science ®Google Scholar
• Newton KM, Reed SD, Guthrie KA, et al. Efficacy of yoga for vasomotor symptoms: a randomized controlled trial. Menopause 2014;21:339–46
   PubMed Web of Science ®Google Scholar
• Sternfeld B, Guthrie KA, Ensrud KE, et al. Efficacy of exercise for menopausal symptoms. a randomized controlled trial. Menopause 2014;21:330–8
   PubMed Web of Science ®Google Scholar
• Daley A, Stokes-Lampard H, Thomas A, et al. Exercise for vasomotor menopausal symptoms. Cochrane Database Syst Rev 2014;(11):CD006108
   PubMed Web of Science ®Google Scholar
• Saensak S, Vutyavanich T, Somboonporn W, et al. Relaxation for perimenopausal and postmenopausal symptoms. Cochrane Database Syst Rev 2014;(7):CD008582
   PubMed Web of Science ®Google Scholar
• Franco OH, Chowdhury R, Troup J, et al. Use of plant-based therapies and menopausal symptoms: a systematic review and meta-analysis. JAMA 2016;315:2554–63
   PubMed Web of Science ®Google Scholar
• Sarri G, Davies M, Lumsden MA. Diagnosis and management of menopause: summary of NICE guidance. BMJ 2015;351:h5746
   PubMed Web of Science ®Google Scholar
• Nonhormonal management of menopause-associated vasomotor symptoms: 2015 position statement of The North American Menopause Society. Menopause 2015;22:1155–72
   PubMed Web of Science ®Google Scholar
• Gold EB, Colvin A, Avis N, et al. Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: study of Women's Health Across the Nation. Am J Public Health 2006;96:1226–35
   PubMed Web of Science ®Google Scholar
• Barton DL, LaVasseur BI, Sloan JA, et al. Phase III, placebo-controlled trial of three doses of citalopram for the treatment of hot flashes: NCCTG trial N05C9. J Clin Oncol 2010;28:3278–83
   PubMed Web of Science ®Google Scholar
• Freeman EW, Guthrie KA, Caan B, et al. Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial. JAMA 2011;305:267–74
   PubMed Web of Science ®Google Scholar
• Stearns V, Beebe KL, Iyengar M, et al. Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial. JAMA 2003;289:2827–34
   PubMed Web of Science ®Google Scholar
• Stearns V, Slack R, Greep N, et al. Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trial. JCO 2005;23:6919–30
   PubMed Web of Science ®Google Scholar
• Loprinzi CL, Kugler JW, Sloan JA, et al. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. Lancet 2000;356:2059–63
   PubMed Web of Science ®Google Scholar
• Archer DF, Seidman L, Constantine GD, et al. A double-blind, randomly assigned, placebo-controlled study of desvenlafaxine efficacy and safety for the treatment of vasomotor symptoms associated with menopause. Am J Obstet Gynecol 2009;200:172.e1–10
   PubMed Web of Science ®Google Scholar
• Johns C, Seav SM, Dominick SA, et al. Informing hot flash treatment decisions for breast cancer survivors: a systematic review of randomized trials comparing active interventions. Breast Cancer Res Treat 2016;156:415–26
   PubMed Web of Science ®Google Scholar
• Hervik JB, Stub T. Adverse effects of non-hormonal pharmacological interventions in breast cancer survivors, suffering from hot flashes: a systematic review and meta-analysis. Breast Cancer Res Treat 2016;160:223–36
   PubMed Web of Science ®Google Scholar
• Loprinzi CL, Qin R, Baclueva EP, et al. Phase III, randomized, double-blind, placebo-controlled evaluation of pregabalin for alleviating hot flashes, N07C1. JCO 2010;28:6417
   Google Scholar
• Rada G, Capurro D, Pantoja T, et al. Non-hormonal interventions for hot flushes in women with a history of breast cancer. Cochrane Database Syst Rev. 2010;(9):CD004923
   PubMed Web of Science ®Google Scholar
• Drewe J, Bucher KA, Zahner C. A systematic review of non-hormonal treatments of vasomotor symptoms in climacteric and cancer patients. Springerplus 2015;4:65
   PubMed Web of Science ®Google Scholar
• Edwards D, Panay N. Treating vulvovaginal atrophy/genitourinary syndrome of menopause: how important is vaginal lubricant and moisturizer composition? Climacteric 2016;19:151–61
   PubMed Web of Science ®Google Scholar
• Andelloux M. Products for sexual lubrication: understanding and addressing options with your patients. Nurs Womens Health 2011;15:253–7
   PubMedGoogle Scholar
• Hickey M, Marino JL, Braat S, et al. A randomized, double-blind, crossover trial comparing a silicone- versus water-based lubricant for sexual discomfort after breast cancer. Breast Cancer Res Treat 2016;158:79–90
   PubMed Web of Science ®Google Scholar
• Juraskova I, Jarvis S, Mok K, et al. The acceptability, feasibility, and efficacy (phase I/II study) of the OVERcome (Olive Oil, Vaginal Exercise, and MoisturizeR) intervention to improve dyspareunia and alleviate sexual problems in women with breast cancer. J Sex Med 2013;10:2549–58
   PubMed Web of Science ®Google Scholar
• Goetsch MF, Lim JY, Caughey AB. A practical solution for dyspareunia in breast cancer survivors: a randomized controlled trial. JCO 2015;33:3394–400
   PubMedGoogle Scholar
• Song S, Budden A, Short A, et al. The evidence for laser treatments to the vulvo-vagina: making sure we do not repeat past mistakes. Obstet Gynecol Surv 2018;3:150
   Google Scholar
• Hickey M, Emery LI, Gregson J, et al. The multidisciplinary management of menopausal symptoms after breast cancer: a unique model of care. Menopause 2010;17:727–33
   PubMed Web of Science ®Google Scholar
• Hickey M, Saunders C, Partridge A, et al. Practical clinical guidelines for assessing and managing menopausal symptoms after breast cancer. Ann Oncol 2008;19:1669–80
   PubMed Web of Science ®Google Scholar
• Cohen PA, Brennan A, Marino JL, et al. Managing menopausal symptoms after breast cancer – A multidisciplinary approach. Maturitas 2017;105:4–7
   PubMed Web of Science ®Google Scholar